(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.58%) $78.56
(1.96%) $2.18
(0.06%) $2 310.10
(0.58%) $26.85
(0.03%) $965.60
(-0.35%) $0.929
(-1.39%) $10.84
(-0.12%) $0.797
(0.52%) $91.61
5 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
-5.60% KRW 75 900
Live Chart Being Loaded With Signals
Celltrion Healthcare Co., Ltd. engages in the manufacture, processing, and sale of biosimilar and biological medicines to patients around the world. Its products include Remsima, a monoclonal antibody biosimilar that is used for rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, Crohn's disease in children, psoriasis, and psoriatic arthritis; Truxima, which is used for lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis and microscopic polyangiitis, and rheumatoid arthritis; Herzuma that is used for metastatic breast cancer, early breast cancer, and metastatic gastric cancer; and Remsima SC, which is used for rheumatoid arthritis...
Stats | |
---|---|
Volumen de hoy | 0.00 |
Volumen promedio | 646 242 |
Capitalización de mercado | 10 736.44B |
EPS | KRW0 ( 2024-03-18 ) |
Próxima fecha de ganancias | ( KRW0 ) 2024-05-10 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW1 815.66 (2.39%) |
Volumen Correlación
Celltrion Healthcare Co., Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Celltrion Healthcare Co., Correlación - Moneda/Commodity
Celltrion Healthcare Co., Finanzas
Annual | 2022 |
Ingresos: | KRW1 972.19B |
Beneficio Bruto: | KRW561.75B (28.48 %) |
EPS: | KRW912.03 |
FY | 2022 |
Ingresos: | KRW1 972.19B |
Beneficio Bruto: | KRW561.75B (28.48 %) |
EPS: | KRW912.03 |
Financial Reports:
No articles found.
Celltrion Healthcare Co.,
Celltrion Healthcare Co., Ltd. engages in the manufacture, processing, and sale of biosimilar and biological medicines to patients around the world. Its products include Remsima, a monoclonal antibody biosimilar that is used for rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, Crohn's disease in children, psoriasis, and psoriatic arthritis; Truxima, which is used for lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis and microscopic polyangiitis, and rheumatoid arthritis; Herzuma that is used for metastatic breast cancer, early breast cancer, and metastatic gastric cancer; and Remsima SC, which is used for rheumatoid arthritis. The company was formerly known as Nexol, Inc. and changed its name to Celltrion Healthcare Co., Ltd. in March 2009. Celltrion Healthcare Co., Ltd. was founded in 1999 and is headquartered in Incheon, South Korea.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico